Patients with HIV who are resistant to all four antiretroviral drug classes face a higher risk for death than those who are ...

His study showed that around 5 percent of HIV-infected children who receive antiretrovirals within the first six months of ...

In Kenya, HIV funding from the U.S. in fiscal year 2024 totaled $307.9 million, equivalent to almost a third of the country’s ...

Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...

With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

Gilead Sciences on Thursday reported flat second-quarter earnings on slightly higher revenue and raised its full-year ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

I was sent to different posts, and one of the rooms was for the HIV testing,” says a woman we spoke with during a visit to the clinic last week. “I guess it’s a good thing, but they have to explain ...

Starting in the mid-2010s, the University of Oxford pediatrician and immunologist began working with scientists in the South African province of KwaZulu-Natal, with the aim of tracking several hundred ...

Cases of human immunodeficiency virus (HIV) in Pangasinan is rising. From January to July this year, the province has ...

Advances in medicine mean more people are living longer with HIV. But aging with HIV comes with increased health risks, and this growing population needs specialized care that's hard to find.